How has been the historical performance of Mono Pharmacare?

Answer:The historical performance of Mono Pharmacare shows a positive trend in key financial metrics from March 2024 to March 2025. Breakdown: In the fiscal year ending March 2025, Mono Pharmacare reported net sales of 168.34 Cr, an increase from 122.34 Cr in the previous year. Total operating income also rose to 168.34 Cr from 122.34 Cr, while total expenditure increased to 160.71 Cr from 116.01 Cr. The operating profit (PBDIT) grew to 8.61 Cr from 6.43 Cr, reflecting an operating profit margin of 4.53%, down from 5.17%. Profit before tax improved to 4.46 Cr from 3.23 Cr, leading to a profit after tax of 3.11 Cr, up from 2.46 Cr. The consolidated net profit increased to 3.09 Cr from 2.44 Cr, with earnings per share rising to 1.75 from 1.38. On the balance sheet, total assets grew to 110.01 Cr from 81.10 Cr, with total liabilities also increasing to 110.01 Cr from 81.10 Cr. Cash flow from operating activities showed a negative trend, with a cash flow of -4.00 Cr compared to -8.00 Cr in the prior year. Overall, the company demonstrated growth in sales and profits, although it faced challenges in cash flow management.